ContractSpecial Notice8(a) Sole Source

NOTICE OF INTENT FOR SOMASCAN ASSAY KITS

DEPARTMENT OF HEALTH AND HUMAN SERVICES• NOI-NIAID-26-2280298
Response Deadline
May 13, 2026
Deadline passed
Days Remaining
0
Closed
Set-Aside
8(a) Sole Source
Notice Type
Special Notice

Contract Opportunity Analysis

NIAID, part of the National Institutes of Health within HHS, intends to make a sole-source, firm-fixed-price purchase order to SomaLogic Operating Co., Inc. for SomaScan 7K and 11K assay kits to support the Center for Human Immunology and related NIH research and clinical trials. The acquisition covers 15 kits for analysis of clinical samples including serum, plasma, cell lysates, tissue homogenates, urine, and cerebrospinal fluid, using a platform that measures up to 11,000 proteins with low sample volume and high reproducibility. The need is tied to ongoing sample batching work at CHI and the requirement to preserve data comparability with previously generated longitudinal results, with performance expected for a one-year period and delivery to Bethesda, Maryland. The stated acquisition value is $522,030, and interested parties with comparable capabilities may submit a capability statement by 5:00 pm EST on May 13, 2026.

Classification Codes

NAICS Code
325414
Biological Product (except Diagnostic) Manufacturing
PSC Code
6550
IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS

Solicitation Documents

2 Files

Related Contract Opportunities

Project Timeline

postedOriginal Solicitation PostedMay 7, 2026
deadlineResponse DeadlineMay 13, 2026
expiryArchive DateMay 14, 2026

Agency Information

Department
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Sub-Tier
NATIONAL INSTITUTES OF HEALTH
Office
NATIONAL INSTITUTES OF HEALTH NIAID

Point of Contact

Name
Jessica Emerson

Place of Performance

Bethesda, Maryland, UNITED STATES

Official Sources